Loading...
Docoh

International Flavors & Fragrances (IFF)

IFF uses Uncommon Sense to create what the world needs. As a collective of unconventional thinkers and creators, the Company puts science and artistry to work to create unique and unexpected scents, tastes, experiences and ingredients for the products its world craves.

Company profile

Ticker
IFF
Exchange
Website
CEO
Andreas Fibig
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
International Flavors & Fragrances S.R.L. • Solae Argentina S.A. • Danisco Argentina S.A. • Bush Boake Allen Australia Pty Ltd • IFF Australia Holdings Pty Ltd • International Flavours & Fragrances (Australia) Pty Ltd • Lucas Meyer Cosmetics Australia Pty Ltd • Southern Cross Botanicals Pty Ltd • Enzymotec Australia PTY LTD • Taura Natural Ingredients (Australia) Holdings Pty Limited ...
IRS number
131432060

IFF stock data

Calendar

9 May 22
26 Jun 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 662M 662M 662M 662M 662M 662M
Cash burn (monthly) 18M 18.25M (no burn) (no burn) 1.33M (no burn)
Cash used (since last report) 51.76M 52.48M n/a n/a 3.83M n/a
Cash remaining 610.24M 609.52M n/a n/a 658.17M n/a
Runway (months of cash) 33.9 33.4 n/a n/a 493.6 n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
15 Jun 22 Robert G. Anderson Stock Equivalent Unit Common Stock Grant Acquire A No No 116.43 11.977 1.39K 6,274.087
1 Jun 22 de Villeplee Christophe Fauchon Common Stock Sell Dispose S No Yes 132.59 629 83.4K 8,180
27 May 22 Robert G. Anderson Stock Equivalent Unit Common Stock Grant Acquire A No No 132.96 10.488 1.39K 6,262.11
13 May 22 Robert G. Anderson Stock Equivalent Unit Common Stock Grant Acquire A No No 132.16 10.552 1.39K 6,251.622
5 May 22 Kathryn Jean Boor Stock Equivalent Unit Common Stock Grant Acquire A No No 0 1,089 0 1,089
5 May 22 Kathryn Jean Boor RSU Common Stock Sale back to company Dispose D No No 0 1,089 0 0
4 May 22 Kathryn Jean Boor RSU Common Stock Grant Acquire A No No 0 1,245 0 1,245
90.0% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 718 769 -6.6%
Opened positions 59 119 -50.4%
Closed positions 110 77 +42.9%
Increased positions 302 264 +14.4%
Reduced positions 225 260 -13.5%
13F shares Current Prev Q Change
Total value 30.05B 34.89B -13.9%
Total shares 229.27M 231.79M -1.1%
Total puts 369.7K 606K -39.0%
Total calls 459.3K 986.5K -53.4%
Total put/call ratio 0.8 0.6 +31.0%
Largest owners Shares Value Change
Vanguard 30.73M $4.04B +1.5%
Winder Investment Pte 25.11M $3.3B 0.0%
BLK Blackrock 19.97M $2.62B +4.0%
TROW T. Rowe Price 12.7M $1.67B +37.2%
STT State Street 10.99M $1.45B -1.4%
Sachem Head Capital Management 6.43M $844.96M -6.0%
Massachusetts Financial Services 5.7M $748.56M +36.6%
Geode Capital Management 4.83M $632.16M +5.2%
Barrow Hanley Mewhinney & Strauss 4.72M $620.1M -2.6%
LTS One Management 4.47M $587.05M -14.9%
Largest transactions Shares Bought/sold Change
TROW T. Rowe Price 12.7M +3.44M +37.2%
Viking Global Investors 3.8M +3.29M +643.1%
Capital International Investors 3.16M -2.74M -46.5%
Nuveen Asset Management 2.75M -1.9M -40.9%
Massachusetts Financial Services 5.7M +1.53M +36.6%
Laurion Capital Management 2.16M -1.11M -33.8%
SG Americas Securities 17.54K -889.22K -98.1%
BCS Barclays 269.35K -879.61K -76.6%
Alliancebernstein 3.13M -834.23K -21.1%
LTS One Management 4.47M -780K -14.9%

Financial report summary

?
Competition
GivaudanSymrise
Risks
  • Inflationary trends in the price of our input costs, such as raw materials, transportation and energy, could adversely affect our business and financial results.
  • Supply chain disruptions, geopolitical developments or climate-change events may adversely affect our suppliers or our procurement of raw materials, and thus may impact our business and financial results.
  • The COVID-19 pandemic may materially and adversely impact our operations, financial condition, results of operations and cash flows.
  • The integration of the N&B Business may continue to present significant challenges, and we may not realize anticipated synergies and other benefits of the N&B Transaction.
  • We have a substantial amount of indebtedness that could materially adversely affect our financial condition.
  • We may not realize all the synergies and other benefits anticipated from the Frutarom acquisition, which could adversely affect our business.
  • If we are unable to successfully market to our expanded and diverse customer base, our operating results and future growth may be adversely affected.
  • Failure to successfully establish and manage acquisitions, collaborations, joint ventures or partnerships, or the failure to close strategic transactions or divestments, could adversely affect our growth.
  • Our business is highly competitive, and if we are unable to compete effectively our sales and results of operations will suffer.
  • Our success depends on attracting and retaining talented people within our business. Significant shortfalls in recruitment or retention could adversely affect our ability to compete and achieve our strategic goals.
  • A significant portion of our sales is generated from a limited number of large multi-national customers, which are currently under competitive pressures that may affect the demand for our products and profitability.
  • We may not successfully develop and introduce new products that meet our customers’ needs, which may adversely affect our results of operations.
  • Natural disasters, public health crises (such as the COVID-19 pandemic), international conflicts, geopolitical events, terrorist acts, labor strikes, political crisis, accidents and other events could adversely affect our business and financial results by disrupting development, manufacturing, distribution or sale of our products.
  • A significant data breach or other disruption to our information technology systems could disrupt our operations, result in the loss of confidential information or personal data, and adversely impact our reputation, business or results of operations.
  • We have made investments in and continue to expand our business into emerging markets, which exposes us to certain risks.
  • The impact of currency fluctuation or devaluation in the international markets in which we operate may negatively affect our results of operations.
  • International economic, political, legal, compliance and business factors could negatively affect our financial statements, operations and growth.
  • Economic uncertainty, including increased inflation, may adversely affect demand for our products which may have a negative impact on our operating results and future growth.
  • If we are unable to react in a timely and cost-effective manner to changes in consumer trends, such as increasing awareness of health and wellness our results of operations and future growth may be adversely affected.
  • We are subject to increasing customer, consumer, shareholder and regulatory focus on sustainability, which may result in additional costs in order to meet new requirements or integrate the N&B Business and Frutarom with our sustainability practices.
  • Our performance may be adversely impacted if we are not successful in managing our inventory and/or working capital balances.
  • Any impairment of our tangible or intangible long-lived assets, including goodwill, may adversely impact our profitability.
  • Our funding obligations for our pension and postretirement plans could adversely affect our earnings and cash flows.
  • The expected phase out of the London Interbank Office Rate (“LIBOR”) could impact the interest rates paid on our variable rate indebtedness and cause our interest expense to increase.
  • Our business may be negatively impacted as a result of the United Kingdom’s departure from the European Union.
  • If we are unable to comply with regulatory requirements and industry standards, including those regarding product safety, quality, efficacy and environmental impact, we could incur significant costs and suffer reputational harm which could adversely affect results of operations.
  • Defects, quality issues (including product recalls), inadequate disclosure or misuse with respect to the products and capabilities could adversely affect our business, reputation and results of operations.
  • Our results of operations may be negatively impacted by the outcome of uncertainties related to litigation.
  • Failure to comply with environmental protection laws may cause us to close, relocate or operate one or more of our plants at reduced production levels, and expose us to civil or criminal liability, which could adversely affect our operating results and future growth.
  • We could be adversely affected by violations of the U.S. Foreign Corrupt Practices Act or similar U.S. or foreign anti-bribery and anti-corruption laws and regulations or applicable sanctions laws and regulations in the jurisdictions in which we operate.
  • Our ability to compete effectively depends on our ability to protect our intellectual property rights.
  • Changes in our tax rates, the adoption of new U.S. or international tax legislation, or changes in existing tax laws could expose us to additional tax liabilities that may affect our future results.
  • The N&B Transaction could result in significant tax liability, and we may be obligated to indemnify DuPont for any such tax liability imposed on DuPont.
  • If we fail to comply with data protection laws in the U.S. and abroad, we may be subject to fines, penalties and other costs.
Management Discussion
  • Cost of goods sold includes the cost of materials and manufacturing expenses. R&D includes expenses related to the development of new and improved products and technical product support. S&A expenses include expenses necessary to support our commercial activities and administrative expenses supporting our overall operating activities including compliance with governmental regulations.
  • Sales for the first quarter of 2022 increased $761 million, or 31% on a reported basis, to $3.226 billion, compared to $2.465 billion in the prior year quarter. Sales included approximately $568 million of incremental sales attributable to N&B for the month of January in the 2022 period. In addition, the increase in sales was driven by volume and price increases across the business.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: acquiree, agriculture, analogy, argument, assumption, botanical, charge, conflict, defect, denied, discipline, domestic, earnout, export, external, finest, format, formula, formulation, found, fourteen, geopolitical, hiring, inadequate, inflationary, input, invasion, medicine, misuse, month, people, prescription, procurement, recoverability, Russian, shipping, slight, strain, Ukrainian, vast, weather, worsen, Wright
Removed: abide, accruing, accuracy, Activity, adjust, affirmative, age, agent, amounting, anniversary, annum, approach, assessment, attrition, automatically, bearing, began, Black, Branch, brand, calculate, chapter, check, classification, closest, closure, comparative, comparing, comparison, complying, composed, computed, conform, consistently, Construction, covenant, customary, deductible, default, defense, depending, deviation, dilution, distributed, divest, division, ease, effort, electronically, Employer, enable, enacted, enhanced, ensuring, equal, evolve, exercised, extension, Facilitation, fewer, filer, filing, finalize, finalizing, finite, foot, Friday, funded, funding, historically, identifiable, Identification, inability, inappropriate, incorporation, indenture, Interactive, internally, issuer, judgment, jurisdiction, larger, largest, led, legacy, lessened, loan, macroeconomic, maintenance, managed, mark, maturing, maximum, merged, modification, moved, multiplied, negative, noncurrent, obsolescence, obtain, operated, optional, partnership, penalty, platform, preceding, premium, prepay, producer, PSU, quotient, rated, realignment, reassigned, recast, recently, recovery, redeemed, reduction, registered, Regulation, relevant, relief, remeasured, renewal, reorganization, reorganized, replacement, requiring, restated, resulted, resulting, reviewing, revised, rounding, royalty, RSA, RSU, SAR, satisfaction, scheduled, selling, shell, simplify, Simplifying, slightly, smaller, statutory, stepped, stepping, subsequently, substantially, sum, thereto, title, trading, tranche, transparency, treatment, twenty, unadjusted, unanticipated, unpaid, unvested, unwind, updated, utilized, validity, varying, vested, visibility, voluntarily, WASHINGTON, work

Patents

Utility
Synthesis of Glucan Comprising BETA-1,3 Glycosidic Linkages with Phosphorylase Enzymes
23 Jun 22
Reaction compositions are disclosed herein comprising at least water, alpha-glucose-1-phosphate (alpha-G1P), an acceptor molecule, and a beta-1,3-glucan phosphorylase enzyme.
Utility
Proline Tolerant Tripeptidyl Peptidases and Uses Thereof
9 Jun 22
A method for the production of a hydrolysate comprising: (a) admixing at least one protein or a portion thereof with: (A) at least one endoprotease; and (B) (a′) at least one proline tolerant tripeptidyl peptidase or fermentate comprising a proline tolerant tripeptidyl peptidase predominantly having exopeptidase activity wherein said proline tolerant tripeptidyl peptidase is capable of cleaving tri-peptides from the N-terminus of peptides having: Proline at P1; and synthetic amino acids at P1; or (b′) at least one proline tolerant tripeptidyl peptidase having exopeptidase activity wherein said proline tolerant tripeptidyl peptidase is capable of cleaving tri-peptides from the N-terminus of peptides having: Proline at PV; and synthetic amino acids at PV; and (b) recovering the hydrolysate.
Utility
Consumer Product with Controlled Release, Biodegradable Core-shell Microcapsule Compositions
9 Jun 22
A consumer product with controlled release of an active material is provided, wherein said active material is encapsulated in a biodegradable core-shell microcapsule composition, wherein the shell of the microcapsule is composed of a biopolymer.
Utility
Controlled Release, Biodegradable Core-shell Microcapsule Compositions
9 Jun 22
A biodegradable core-shell microcapsule composition with controlled release of an active material is provided, wherein the shell of the microcapsule is composed of a biopolymer.
Utility
Methods for integrating a donor DNA sequence into the genome of bacillus using linear recombinant DNA constructs and compositions thereof
9 Jun 22
Methods and compositions are provided for integrating donor DNA sequences into the genome of a Bacillus sp. cell without the integration of a selectable marker into said genome.